Observational studyHepatology (Baltimore, Md.)2017

Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.

Varun Saxena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.